Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 192124011000036114 | Simulect (basiliximab 20 mg) powder for injection, 20 mg vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 192125011000036113 | Simulect (basiliximab 20 mg) powder for injection, 20 mg vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Simulect (basiliximab 20 mg) powder for injection, 20 mg vial | has unit of use | vial | true | Inferred relationship | Some | 1331917315 | |
| Simulect (basiliximab 20 mg) powder for injection, 20 mg vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Simulect (basiliximab 20 mg) powder for injection, 20 mg vial | Is a | Simulect | true | Inferred relationship | Some | ||
| Simulect (basiliximab 20 mg) powder for injection, 20 mg vial | Is a | basiliximab 20 mg injection, vial | true | Inferred relationship | Some | ||
| Simulect (basiliximab 20 mg) powder for injection, 20 mg vial | has manufactured dose form | powder for injection | true | Inferred relationship | Some | ||
| Simulect (basiliximab 20 mg) powder for injection, 20 mg vial | has Australian BoSS | basiliximab | true | Inferred relationship | Some | 1331917314 | |
| Simulect (basiliximab 20 mg) powder for injection, 20 mg vial | has intended active ingredient | basiliximab | true | Inferred relationship | Some | 1331917314 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Simulect (1 x 20 mg vial, 1 x 5 mL inert diluent ampoule), 1 pack | has TPUU | True | Simulect (basiliximab 20 mg) powder for injection, 20 mg vial | Inferred relationship | Some | 1 |
| Simulect (basiliximab 20 mg) powder for injection [1 x 20 mg vial] (&) (inert substance) diluent [1 x 5 mL ampoule], 1 pack (containered trade product pack) | has TPUU | True | Simulect (basiliximab 20 mg) powder for injection, 20 mg vial | Inferred relationship | Some | 2 |
Reference Sets
Trade product unit of use reference set
FHIR